{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:37:21Z","timestamp":1773070641108,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005977","name":"Kaiser Permanente","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005977","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajpmfocus.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["AJPM Focus"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.focus.2025.100423","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T23:29:38Z","timestamp":1755905378000},"page":"100423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of SARS-CoV-2 Serology Test Result and COVID-19 Vaccination in Adults: A Multisite Cohort Study"],"prefix":"10.1016","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1950-7034","authenticated-orcid":false,"given":"Jason M.","family":"Glanz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3318-0506","authenticated-orcid":false,"given":"Darryl E.","family":"Palmer-Toy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Komal J.","family":"Narwaney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer C.","family":"Barrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8277-2431","authenticated-orcid":false,"given":"Katia J.","family":"Bruxvoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney R.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-1354-7103","authenticated-orcid":false,"given":"Jason A.","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8862-8078","authenticated-orcid":false,"given":"Ingrid A.","family":"Binswanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.focus.2025.100423_bib0001","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2105\/AJPH.2021.306273","article-title":"Emergency use authorizations (EUAs) versus FDA approval: implications for COVID-19 and public health","volume":"111","author":"Zuckerman","year":"2021","journal-title":"Am J Public Health"},{"key":"10.1016\/j.focus.2025.100423_bib0002","unstructured":"Coronavirus (COVID-19) update: daily roundup May 4, 2020. Food and Drug Administration. https:\/\/www.fda.gov\/news-events\/press-announcements\/coronavirus-covid-19-update-daily-roundup-may-4-2020. Accessed August 2, 2024."},{"key":"10.1016\/j.focus.2025.100423_bib0003","unstructured":"In vitro diagnostics emergency use authorizations (EUAs)-serology and other adaptive immune response tests for SARS-CoV-2.https:\/\/www.fda.gov\/medical-devices\/covid-19-emergency-use-authorizations-medical-devices\/in-vitro-diagnostics-emergency-use-authorizations-euas-serology-and-other-adaptive-immune-response. Updated 2020. Accessed August 15, 2024."},{"issue":"22","key":"10.1016\/j.focus.2025.100423_bib0004","doi-asserted-by":"crossref","first-page":"601","DOI":"10.15585\/mmwr.mm7222a3","article-title":"Estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status\u2014United States, April 2021\u2013September 2022","volume":"72","author":"Jones","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"14","key":"10.1016\/j.focus.2025.100423_bib0005","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.2021.15161","article-title":"Estimated U.S. infection- and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020\u2013May 2021","volume":"326","author":"Jones","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.focus.2025.100423_bib0006","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061497","article-title":"Studies of prevalence: how a basic epidemiology concept has gained recognition in the COVID-19 pandemic","volume":"12","author":"Buitrago-Garcia","year":"2022","journal-title":"BMJ Open"},{"issue":"18","key":"10.1016\/j.focus.2025.100423_bib0007","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/jama.2021.18919","article-title":"The flawed science of antibody testing for SARS-CoV-2 immunity","volume":"326","author":"Abbasi","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.focus.2025.100423_bib0008","unstructured":"Centers for Disease Control and Prevention. Interim Guidelines for COVID-19 Antibody Testing.https:\/\/archive.cdc.gov\/#\/details?q=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/testing\/antibody-tests-guidelines.html&start=0&rows=10&url=https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/testing\/antibody-tests-guidelines.html. | CDC Archive; Updated December 16, 2022. Accessed January 30, 2023."},{"key":"10.1016\/j.focus.2025.100423_bib0009","unstructured":"Antibody (serology) testing for COVID-19: information for patients and consumers. U.S. Food and Drug Administration.https:\/\/www.fda.gov\/medical-devices\/coronavirus-covid-19-and-medical-devices\/antibody-serology-testing-covid-19-information-patients-and-consumers. Updated April 24, 2025. Accessed May 11, 2022."},{"issue":"7","key":"10.1016\/j.focus.2025.100423_bib0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJMp2033687","article-title":"The FDA\u2019s experience with Covid-19 antibody tests","volume":"384","author":"Shuren","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.focus.2025.100423_bib0011","doi-asserted-by":"crossref","first-page":"ofac674","DOI":"10.1093\/ofid\/ofac674","article-title":"Tale of the titers: serologic testing for SARS-CoV-2-Yes, no, and maybe, with clinical examples from the IDSA diagnostics committee","volume":"10","author":"Colgrove","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"10.1016\/j.focus.2025.100423_bib0012","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tim.2020.11.002","article-title":"COVID-19 antibody tests: a valuable public health tool with limited relevance to individuals","volume":"29","author":"West","year":"2021","journal-title":"Trends Microbiol"},{"issue":"3","key":"10.1016\/j.focus.2025.100423_bib0013","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00201-21","article-title":"Antibody (serology) tests for COVID-19: a case study","volume":"6","author":"West","year":"2021","journal-title":"mSphere"},{"issue":"2","key":"10.1016\/j.focus.2025.100423_bib0014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/ip.6.2.82","article-title":"Risky business: safety regulations, risks compensation, and individual behavior","volume":"6","author":"Hedlund","year":"2000","journal-title":"Inj Prev"},{"issue":"4","key":"10.1016\/j.focus.2025.100423_bib0015","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1086\/260352","article-title":"The effects of automobile safety regulation","volume":"83","author":"Peltzman","year":"1975","journal-title":"J Pol Econ"},{"issue":"4","key":"10.1016\/j.focus.2025.100423_bib0016","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/109019817400200407","article-title":"The health belief model and sick role behavior","volume":"2","author":"Becker","year":"1974","journal-title":"Health Educ Monogr"},{"issue":"6","key":"10.1016\/j.focus.2025.100423_bib0017","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/vaccines10060973","article-title":"The health belief model applied to COVID-19 vaccine hesitancy: a systematic review","volume":"10","author":"Limbu","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"10","key":"10.1016\/j.focus.2025.100423_bib0018","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.3390\/vaccines9101100","article-title":"Overcoming COVID-19 vaccine hesitancy: insights from an online population-based survey in the United States","volume":"9","author":"Badr","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.focus.2025.100423_bib0021","unstructured":"Abbott Laboratories Diagnostics. Division. SARS-CoV-2 IgG. 2020.https:\/\/www.corelaboratory.abbott\/int\/en\/offerings\/segments\/infectious-disease\/sars-cov-2.html. Updated May 26, 2020. Accessed January 30, 2023."},{"issue":"8","key":"10.1016\/j.focus.2025.100423_bib0022","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00941-20","article-title":"Performance characteristics of the Abbott Architect SARS-CoV-2 IgG assay and seroprevalence in Boise, Idaho","volume":"58","author":"Bryan","year":"2020","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.focus.2025.100423_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.889138","article-title":"SARS-CoV-2-mRNA booster vaccination reverses non-responsiveness and early antibody waning in immunocompromised patients - A Phase Four study comparing immune responses in patients with solid cancers, multiple myeloma and inflammatory bowel disease","volume":"13","author":"Wagner","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.focus.2025.100423_bib0024","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2021.12.011","article-title":"Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: should humoral responses be monitored? A position article","volume":"162","author":"Barri\u00e8re","year":"2022","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.focus.2025.100423_bib0025","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1037\/rev0000449","article-title":"The relation between learning and stimulus-response binding","volume":"131","author":"Frings","year":"2024","journal-title":"Psychol Rev"},{"issue":"14","key":"10.1016\/j.focus.2025.100423_bib0026","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.focus.2025.100423_bib0027","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.7326\/M21-4204","article-title":"Development and validation of the summary Elixhauser comorbidity score for use with ICD-10-CM-coded data among older adults","volume":"175","author":"Mehta","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.focus.2025.100423_bib0028","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"2","key":"10.1016\/j.focus.2025.100423_bib0029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/ajhp\/zxab344","article-title":"COVID-19 vaccine use in immunocompromised patients: a commentary on evidence and recommendations","volume":"79","author":"Duly","year":"2022","journal-title":"Am J Health Syst Pharm"},{"issue":"6","key":"10.1016\/j.focus.2025.100423_bib0030","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1136\/annrheumdis-2021-222045","article-title":"Efficacy of COVID-19 vaccines in patients taking immunosuppressants","volume":"81","author":"Shen","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.focus.2025.100423_bib0031","doi-asserted-by":"crossref","first-page":"19","DOI":"10.15585\/mmwr.mm7101a4","article-title":"Risk factors for severe COVID-19 outcomes among persons aged\u2265 18 years who completed a primary COVID-19 vaccination series - 465 Health Care Facilities, United States, December 2020-October 2021","volume":"71","author":"Yek","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.focus.2025.100423_bib0032","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2665-9913(21)00325-8","article-title":"Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative","volume":"4","author":"Andersen","year":"2022","journal-title":"Lancet Rheumatol"},{"issue":"4","key":"10.1016\/j.focus.2025.100423_bib0033","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1540-6237.2007.00510.x","article-title":"Risk compensation or risk reduction? Seatbelts, state laws, and traffic fatalities","volume":"88","author":"Houston","year":"2007","journal-title":"Soc Sci Q"},{"issue":"4","key":"10.1016\/j.focus.2025.100423_bib0034","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S0749-3797(01)00378-6","article-title":"Reviews of evidence regarding interventions to increase the use of safety belts","volume":"21","author":"Dinh-Zarr","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.focus.2025.100423_bib0035","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.trf.2018.10.026","article-title":"Bicycle helmets and risky behaviour: a systematic review","volume":"60","author":"Esmaeilikia","year":"2019","journal-title":"Transp Res F"},{"issue":"suppl 6","key":"10.1016\/j.focus.2025.100423_bib0036","article-title":"Give PrEP a chance: moving on from the \u201crisk compensation\u201d concept","volume":"22","author":"Rojas Castro","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"13","key":"10.1016\/j.focus.2025.100423_bib0037","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2024.29.13.2300451","article-title":"Questioning risk compensation: pre-exposure prophylaxis (PrEP) and sexually transmitted infections among men who have sex with men, capital region of Denmark, 2019 to 2022","volume":"29","author":"von Schreeb","year":"2024","journal-title":"Euro Surveill"},{"issue":"5","key":"10.1016\/j.focus.2025.100423_bib0038","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s10461-019-02720-4","article-title":"No evidence of sexual risk compensation following PrEP initiation among heterosexual HIV serodiscordant couples in Kenya and Uganda","volume":"24","author":"Ortblad","year":"2020","journal-title":"AIDS Behav"},{"issue":"1","key":"10.1016\/j.focus.2025.100423_bib0039","doi-asserted-by":"crossref","DOI":"10.1136\/bmjph-2023-000725","article-title":"Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the naloxone Navigator randomised clinical trial","volume":"2","author":"Glanz","year":"2024","journal-title":"BMJ Public Health"},{"issue":"4","key":"10.1016\/j.focus.2025.100423_bib0040","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1017\/S1744133119000136","article-title":"HPV vaccine status and sexual behavior among young sexually-active women in the U.S.: evidence from the National Health and Nutrition Examination Survey, 2007\u20132014","volume":"15","author":"Leidner","year":"2020","journal-title":"Health Econ Policy Law"},{"issue":"6","key":"10.1016\/j.focus.2025.100423_bib0041","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0001-4575(94)90056-6","article-title":"Seat-belt legislation and risk homeostasis: further analysis of the British data","volume":"26","author":"Shannon","year":"1994","journal-title":"Accid Anal Prev"},{"issue":"1","key":"10.1016\/j.focus.2025.100423_bib0042","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/001872088202400105","article-title":"Compulsory seat belt usage and driver risk-taking behavior","volume":"24","author":"Evansm","year":"1982","journal-title":"Hum Factors"},{"issue":"1","key":"10.1016\/j.focus.2025.100423_bib0043","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1038\/s41598-021-82574-w","article-title":"Risk compensation and face mask mandates during the COVID-19 pandemic","volume":"11","author":"Yan","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.focus.2025.100423_bib0044","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279347","article-title":"Does receiving a SARS-CoV-2 antibody test result change COVID-19 protective behaviors? Testing risk compensation in undergraduate students with a randomized controlled trial","volume":"17","author":"Ludema","year":"2022","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.focus.2025.100423_bib0045","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/medethics-2020-106365","article-title":"Passport to freedom? Immunity passports for COVID-19","volume":"46","author":"Brown","year":"2020","journal-title":"J Med Ethics"},{"issue":"2","key":"10.1016\/j.focus.2025.100423_bib0046","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/aphw.12262","article-title":"The health belief model predicts vaccination intentions against COVID-19: a survey experiment approach","volume":"13","author":"Zampetakis","year":"2021","journal-title":"Appl Psychol Health Well Being"},{"issue":"10","key":"10.1016\/j.focus.2025.100423_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000934","article-title":"Using a health belief model to assess COVID-19 vaccine intention and hesitancy in Jakarta, Indonesia","volume":"2","author":"Hidayana","year":"2022","journal-title":"PLoS Glob Public Health"},{"issue":"2","key":"10.1016\/j.focus.2025.100423_bib0048","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/00333549111260S215","article-title":"Parental delay or refusal of vaccine doses, childhood vaccination coverage at 24 months of age, and the Health Belief Model","volume":"126","author":"Smith","year":"2011","journal-title":"Public Health Rep"},{"key":"10.1016\/j.focus.2025.100423_bib0049","unstructured":"Center for Disease Control and Prevention. ACIP Vaccine Recommendations and Schedules. | ACIP | CDC.https:\/\/www.cdc.gov\/acip\/vaccine-recommendations\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/vaccines\/acip\/recommendations.html. Updated June 28, 2024. Accessed August 2, 2024."},{"issue":"23","key":"10.1016\/j.focus.2025.100423_bib0050","doi-asserted-by":"crossref","first-page":"757","DOI":"10.15585\/mmwr.mm7123a2","article-title":"COVID-19 vaccination coverage, by race and ethnicity - national immunization survey adult COVID module, United States, December 2020\u2013November 2021","volume":"71","author":"Kriss","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"36","key":"10.1016\/j.focus.2025.100423_bib0051","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1016\/j.vaccine.2015.07.037","article-title":"Demographic characteristics of members of the Vaccine Safety Datalink (VSD): a comparison with the United States population","volume":"33","author":"Sukumaran","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.focus.2025.100423_bib0052","doi-asserted-by":"crossref","first-page":"87","DOI":"10.7812\/TPP\/22.172","article-title":"Comparing Kaiser Permanente members to the general population: implications for generalizability of research","volume":"27","author":"Davis","year":"2023","journal-title":"Perm J"},{"key":"10.1016\/j.focus.2025.100423_bib0053","doi-asserted-by":"crossref","DOI":"10.1177\/1179173X211068027","article-title":"COVID-19 vaccination uptake and hesitancy among current tobacco users","volume":"14","author":"Krebs","year":"2021","journal-title":"Tob Use Insights"}],"container-title":["AJPM Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065425001117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2773065425001117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:27:06Z","timestamp":1773052026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2773065425001117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2773065425001117"],"URL":"https:\/\/doi.org\/10.1016\/j.focus.2025.100423","relation":{},"ISSN":["2773-0654"],"issn-type":[{"value":"2773-0654","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of SARS-CoV-2 Serology Test Result and COVID-19 Vaccination in Adults: A Multisite Cohort Study","name":"articletitle","label":"Article Title"},{"value":"AJPM Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.focus.2025.100423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100423"}}